Speaking Engagement

Innovation Interrupted? Navigating Life Sciences Policy in 2025

May 15, 2025

The new administration is changing the paradigm for life sciences funding and regulation. At this lunch and learn session, Foley Hoag Partner, Andrew London, will discuss the latest updates on what's happening in Washington and how it may affect companies, including:
  • How shifts in healthcare policy priorities have shaped priorities at the FDA, HHS, and NIH
  • Which regulatory and funding changes may affect innovation.
  • The potential impacts of the IRA and 340B Program on Drug Pricing and Development.
  • The potential implications of Bayh-Dole Act enforcement and March-In rights on federally funded research and IP ownership.
For more information on CVilleBioHub please visit their website: https://cvillebiohub.org/about/.